Diligence memo · auto-generated · as of July 3, 2026
Nexion Biosciences Inc
Nexion Biosciences Inc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Nexion Biosciences Inc operates in Biotech / Pharma, based in ORLANDO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Nexion Biosciences Inc has raised $814K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $814K on 2017-05-11.
Most recent recorded round closed around 2017-05-11.
Valuation (modeled)modeled
Provath models Nexion Biosciences Inc at approximately $42M (range $445K–$472M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.32× the median modeled value of Pre-Seed Biotech / Pharma companies in 2016–2018 (12 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 9.1 yr ago; this sector typically re-raises about every 15 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 27% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 58% of those peers.
Closest niche peers: Orbis Biosciences, Inc, Synereca Pharmaceuticals, Inc., Novome Biotechnologies, Inc., Me Biosciences, Inc., Continuum Biosciences, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.